243590
Potassium perrhenate
99%
Synonym(s):
Potassium oxido(trioxo)rhenium, Potassium tetraoxorhenate(1-)
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
KReO4
CAS Number:
Molecular Weight:
289.30
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
233-953-8
MDL number:
Assay:
99%
Form:
powder
Quality Level
assay
99%
form
powder
reaction suitability
core: potassium
refractive index
n20/D 1.643 (lit.)
mp
550 °C (lit.)
density
4.887 g/mL at 25 °C (lit.)
SMILES string
[K+].[O-][Re](=O)(=O)=O
InChI
1S/K.4O.Re/q+1;;;;-1;
InChI key
QFKRWIFGDGKWLM-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
The reduction of KReO4 in the preparation of cyclopentadienyltricarbonylrhenium complexes has potential as a model for the syntheses of technetium and rhenium organometallic radiopharmaceuticals.
Storage Class
5.1B - Oxidizing hazardous materials
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Spradau, T.W. Katzenellenbogen, J.A.
Organometallics, 17, 2009-2009 (1998)
Yuee Feng et al.
Inorganic chemistry, 48(23), 11058-11066 (2009-11-06)
The detailed syntheses of complexes of the form [Re(O)(X)(RNCH(2)CH(2))(2)N(Me)] (X = Me, Cl, I, R = mesityl, C(6)F(5)), 1-3, incorporating diamidoamine ancillary ligands are described. X-ray crystal structures for the complexes [Re(O)(Me)((C(6)F(5))NCH(2)CH(2))(2)N(Me)], 1a, [Re(O)(I)((C(6)F(5))N CH(2)CH(2))(2)N(Me)], 3a, and [Re(O)(I)((Mes)NCH(2))(2)N(Me)], 3b, are
Rui Cao et al.
Inorganic chemistry, 50(19), 9499-9507 (2011-08-30)
We describe a multidentate tripodal ligand in which three pendant arms carrying di(2-picolyl)amine units are linked to the ortho positions of a tris(o-xylyl) scaffold, providing N(CH(2)-o-C(6)H(4)CH(2)N(CH(2)py)(2))(3) (L). Reaction of L with CuCl(2) in the presence of hexafluorophosphate anion afforded blue
J Tyler French et al.
Journal of vascular and interventional radiology : JVIR, 21(8), 1271-1279 (2010-05-19)
Minimally invasive interventional cancer therapy with drug-carrying lipid nanoparticles (ie, liposomes) via convection-enhanced delivery by an infusion pump can increase intratumoral drug concentration and retention while facilitating broad distribution throughout solid tumors. The authors investigated the utility of liposome-carrying beta-emitting
Mark J Bailey et al.
Advanced healthcare materials, 1(4), 437-442 (2012-11-28)
Configuring RE(2) O(3) nanocrystals with pseudo-2D morphologies confers substantive gains in relaxivities over equivalent spherical counterparts. The most promising arises from Gd(2) O(3) whose ionic transverse and longitudinal relaxivities were as high as r(1) = 12.7 mM(-1) s(-1) and r(2)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service